CURESPONSE
Curesponse is a medical company developing a three-dimensional tissue culture system for modeling cancer growth and drug response. The company's technology represents the next step in personalized cancer medicine, moving prediction capabilities beyond genomics and into the world of functional response on living patient cells. The platform preserves the cancer tissue architecture, including the vasculature and immune system, accurately reflecting the cancer growth found in the body. Curesponse�... �s cutting edge functional platform will match the correct drug to the patient's cancer, improving survival and saving unnecessary medical interventions. The company is harnessing the technology to create a personalized cancer diagnostic assay that can be used to determine the drug response for a specific individual's tumor type.
CURESPONSE
Industry:
Biotechnology Health Care Medical Medical Device
Founded:
2018-01-01
Address:
Tel Aviv-yafo, Tel Aviv, Israel
Country:
Israel
Website Url:
http://www.curesponse.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
6 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Content Delivery Network Euro GStatic Google Static Content Wix Fastly Hosted
Similar Organizations
Remidio Innovative Solutions
Remidio is engaged in designing & developing disruptive imaging technologies in vision care.
NeuraMatrix
NeuraMatrix is a biotechnology company engaged in developing implantable neural interfaces for neuroscience research and applications.
Nu-Med Plus
Nu-Med Plus is a medical device company that develops a patented technology to safely deliver precision doses of nitric oxide.
Newsoara
Newsoara is a biomedical technology developer that specializes in the development of medical devices.
Nayam Innovations
The company aims to use its patented technology to provide cataract treatment at one-tenth the present cost, and with better outcomes.
NeoImmune
NeoImmune is a developer of technologies for the reading and writing of T and B lymphocyte receptor repertoire and its medical applications.
NuEyne
Nu Eyne is a MedTech company that addresses medical conditions with electroceutical technology. Its flagship product treats dry eye disease.
Venstra Medical
Venstra Medical develop and commercialise percutaneous circulatory support systems.
VLPbio
VLPbio focuses on research and development of chimeric virus like particles (VLPs) as vaccines in animal and human health.
Venari Medical
Venari Medical is an innovative medical device company developing the next-generation treatment for all chronic venous disease patients.
MicroMedMark
MicroMedMark is a biomedical company specialized in vitro diagnostic reagents and drug development services.
MEDP.AI
MEDP.AI is a medical imaging diagnostic aid identification system developer company.
Meticuly
Meticuly is a 3D printing medical technology company focusing on personalised implant solutions for bone-related surgery applications.
Lab n People
LabnPeople is a biotech startup that has developed innovative and minimally invasive surgical and transdermal drug delivery solutions.
Lightpoint Medical
Lightpoint Medical, a medical device company, develops intra-operative imaging technology that can detect cancer during surgery.
Lansion Biotechnology
Lansion Biotechnology is specialized in research & development, production, sell, services of in vitro diagnostic reagents and devices.
liberDi
All-in-one Digital Dialysis Clinic, allowing people treated for kidney disease to safely perform Peritoneal Dialysis anywhere!
Lydus Medical
Lydus Medical is a start-up company that develops a set of tools for anastomosis of small blood vessels.
Longhui Medical
Longhui Medical is a medical robotics R&D company focused on joint replacement surgery robots, product development, sales, and service.
Longe Medikal Sdn Bhd
medical device (accessory), 3D print (medical), healthcare, simulation (medical), digital health
Alivas
Alivas is a medical company that develops new therapeutic medical devices for refractory constipation.
AdipoSeeds
AdipoSeeds aims to create platelets from mesenchymal stem cells and invent new blood supply system.
ABM Respiratory Care
ABM Respiratory Care is a medical device startup that develops ventilation solutions for people suffering from pulmonary diseases.
AmplifiDx
AmplifiDx provides a molecular point of care device combining visual appeal with ease of use, low cost and, high performance.
Asklepios BioPharmaceutical
Asklepios BioPharmaceutical is a biotechnology company developing adeno-associated virus (AAV) gene therapies for genetic disorders.
Adriakaim
Adriakaim developed the innovative device designed for providing electric stimulation to vagus nerve to reduce areas of cardiac infarction.
Aqua Medical
Aqua Medical provides Zreating Gastrointestinal Disease with Disruptive, Vapor-Based Endoscopic Ablation Therapy.
Aorui Bio
Aorui Bio is a biotech R&D company that combines whole genome liquid biopsy and ML tech for wireless cancer early screening technology.
ABL Bio
It is based on developing bispecific antibody cancer programs.
Endomaster
EndoMaster is a medical device company that is developing a novel robotic-assisted surgical system.
BIOMODEX
BIOMODEXÂ is a medical technology company using 3D printing to create tissue-like anatomical twins for rehearsal of surgeries.
Bendit
Bendit is a medical company that develops and manufactures innovative catheters based on a unique bending technology.
DynamX Medical
DynamX Medical has developed a diagnostic system for cancer and pre-cancer.
Berry Oncology
Berry Oncology develops medical technology intended to improve cancer prevention and tumor diagnosis.
Biobeat
Develops solution for remote patient monitoring, able to wirelessly measure 15 vital signs, clinically and regulatory approved
Filterlex Medical
Filterlex Medica is a medical device company that develops embolic protection devices to reduce the risk of stroke and other complications.
ForSight Robotics
ForSight Robotics develops a platform to perform and deliver ophthalmic robotic surgeries.
Tingsheng Technology
Tingsheng Technology develops intra cardiac ultrasound ICE products.
Tevosol
Tevosol, a medical device company, has develop the Ex-Vivo Organ Support System to increase the number of available organs for transplant.
TopGene
TopGene is a tumor precision medical institution specializing in the field of precision medicine for gene detection applications.
Theromics
Theromics is a medical device company advancing novel technologies for interventional radiology and drug delivery.
TYBR Health
TYBR is a medical device company developing a sprayable hydrogel to keep internal organs scar-free after surgery.
Tricares
TRiCares is a medical device company, devoted to developing a catheter-based valve replacement system.
Jajal Medical
Jajal Medical is a medical 3D printing technology company that specializes in creating 3D models from CT scans.
Usono
Usono radically changes the ultrasound application market by improving and innovating the way ultrasound is used.
UniXell
UniXell develops cell therapies for the treatment of cancer and neurodegenerative disorders.
Quest Genomics
Quest Genomics is a tumor genetic testing instruments and reagents research and development company.
Qihan Biotech
Qihan Biotech is a gene-editing organ transplantation technology developer.
Kangso Medical Inspection
Kangxu Medical Laboratory is the first batch of third-party professional testing institutions in China.
Sarkana Pharma
Sarkana Pharma develops an anti-inflammatory biologic to treat certain types of auto-immune diseases.
Sinocelltech
Sinocelltech is a biotech company that develops and manufactures recombinant proteins, monoclonal antibodies, and vaccines.
Superdoc
Superdoc - Consult Doctors is the easiest way for you to ask a doctor any medical question. It’s FREE How it Works: 1.
SentreHEART
SentreHEART is a medical device company developing tissue closure solutions, offering physicians control over remotely delivered sutures.
Sonogen Medical
Sonogen Medical focuses on research, development, and commercialization of ultrasound bone fracture healing technologies.
Drapp
Drapp is a platform allowing billable medical consultations between doctors and patients through a smart chatbot.
Distalmotion
Distalmotion is a Swiss medical device company. We have developed a surgical robot called Dexter to establish a new standard of care.
DAMAE Medical
DAMAE Medical develops an innovative imaging process for quick and non-invasive skin cancer detection.
Drips
Drips is a medical technology company that provides mouthpiece orthodontic service.
DeeDee Labs Pvt Ltd
A technology startup with primary focus on Next Generation Assistive Devices, starting with Upper Limb Bionic Prosthesis.
Hallsey
Hanerxi is a pen injector developer of an adjustable precision injection pen for drug delivery in chronic ailments and diseases.
HekaBio
HekaBio is a comprehensive ecosystem for accelerating healthcare innovations in Japan and Asia Pacific
HoloEyes
The medical field by developing surgical simulation.
Healcerion
HEALCERION is a Korean incubator that offers a mobile-based healthcare system for providing physicians and patients with ultra-portability.
Hesguard
Hesguard is a medical device developer and producer of high-end implantable medical devices related to ophthalmic diseases.
Hannah Life Technologies
Hannah Life Technologies develops new groundbreaking infertility treatments with the goal of making treatment better, easier and accessible
Immunosens
Immunosens is a medical device company that develops immunosensors for immunological tests.
Gelmetix
Gelmetix is a medical device company developing a polymer treatment for chronic lower-back pain.
Glyconics
Glyconics is a diagnostics company, using infrared spectroscopy to analyse samples for markers of disease across a wide range of conditions.
Vero Biotech
Vero Biotech is a biopharmaceutical company that commercializes inhaled nitric oxide delivery systems for healthcare providers.
OncoRes Medical
OncoRes Medical develops an imaging technology to provide intraoperative information available to surgeons.
3Derm Systems
3Derm is a medical technology company offering a skin imaging system that allows users to take clinical-quality 3D skin images remotely.
Cuorips, Inc.
CUORiPS is a company developing new medical care based on world's cutting-edge technology originated in Japan.
Bainian Yihao
Centennial Nickname is positioned in the transformation of biomedical innovations and new drug research
CorFlow Therapeutics AG
CorFlow Therapeutics is a medtech startup that develops proprietary technologies for diagnosis and treatment of microvascular obstructions.
Cykinso
Cykinso is a developer of a home-testing kit designed to tell people the state of their intestinal bacteria.
CoraVie Medical
Early stage med device co. developing a subcutaneous continuous blood pressure monitor for patients with uncontrolled hypertension.
Cancerfree Biotech
CancerFree Biotech is a start-up company dedicated to personalized treatment of cancer.
ConTIPI Medical
ConTIPI Medical is a medical company that provides vaginal solutions for women with various Pelvic Floor Disorder.
Cross Vascular
Cross Vascular is a medical device company that develops proprietary cardiovascular technologies.
Pulse Medical
Pulse Medical is a Cardiovascular interventional medical device research and development producer.
Perfuze
Perfuze is developing innovative medical technology to treat acute ischemic stroke.
Pocket Clinic
Pocket Clinic improves the life of diabetic patients, offering them a personalized solution that can optimize patient’s treatment.
Portela Soni Medical
Portela Soni Medical is a developer of a catheter device designed to solve problems for patients in novel and innovative ways.
PMD Solutions
PMD Solutions is a medical device company developing novel CE marked respiratory diagnostic wearables for the hospital and home market.
Pi-Cardia
Pi-Cardia is a medical device start-up company developing a novel low profile catheter for the treatment of aortic stenosis.
PandaMed
PandaMed is a Medical device developer in the field of diabetes and weight loss.
PHC Holdings
PHC Holdings is a global corporation focused on the development of healthcare and research technology.
Ykrita Life Sciences
YLS develops a medical device to help clinicians treat patients without the need for an organ transplant & hospitalisation.
Current Employees Featured
Founder
Investors List
aMoon Fund
aMoon Fund investment in Series A - CuResponse
NCL Technology Ventures
NCL Technology Ventures investment in Series A - CuResponse
Official Site Inspections
http://www.curesponse.com Semrush global rank: 9.52 M Semrush visits lastest month: 141
- Host name: 169.142.69.34.bc.googleusercontent.com
- IP address: 34.69.142.169
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "CuResponse"
Homepage - Curesponse | Better Cancer Care
Curesponse has developed a 3-dimensional tissue culture system for modeling cancer growth and drug response. The platform, preserves the cancer tissue architecture (including vasculature …See details»
About - Curesponse | Better Cancer Care
Curesponse’s cutting-edge functional platform will empirically match the right drug to each patient’s cancer, improving survival and saving unnecessary medical interventions. …See details»
CuResponse - Crunchbase Company Profile & Funding
Curesponse is a medical company developing a three-dimensional tissue culture system for modeling cancer growth and drug response. The company's technology represents the next step in personalized cancer medicine, moving …See details»
Team - Curesponse | Better Cancer Care
MeetCuresponse The Curesponse team brings together medical executives, business managers, experienced scientists with clinical and regulatory experts. We all have one purpose – to …See details»
Curesponse Company Profile 2024: Valuation, Funding & Investors …
Curesponse General Information Description. Developer of a three-dimensional tissue culture system designed for modeling cancer growth and drug response. The company's platform …See details»
New personalised cancer medicine company moves in …
Nov 17, 2022 Personalised cancer medicine start-up Curesponse has become the latest MedTech company to move in at the Innovation Gateway at The London Cancer Hub in Sutton, south London.. Curesponse has developed a …See details»
CuResponse - Contacts, Employees, Board Members, Advisors
Curesponse is a medical company developing a three-dimensional tissue culture system for modeling cancer growth and drug response.See details»
Israeli Startup Curesponse Targets European Pharma Market With …
Jun 18, 2020 NEW YORK – Following a $6M Series A funding round earlier this month, Israeli personalized medicine company Curesponse will expand into the UK later this year by …See details»
Curesponse Secures Additional USD 8 Million Funding for Its ...
Nov 15, 2021 Curesponse is a cancer precision medicine company whose platform, cResponse, accurately and timely predicts a patient's response to cancer treatment. The company has …See details»
Curesponse Secures $6M Series A for Breakthrough Precision …
Jun 5, 2020 Curesponse is a cancer precision medicine company whose platform, cResponse, accurately and quickly predicts a patient's response to cancer treatment. - The company has …See details»
Curesponse Secures Additional USD 8 Million Funding for Its
REẖOVOT, Israel, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Curesponse (www.curesponse.com) has secured additional USD 8 million funding for its breakthrough precision oncology …See details»
Technology - Curesponse | Better Cancer Care
Curesponse has developed a genomics-functional drug prioritization platform that accurately predicts the most effective cancer treatment for each tumor. The cResponseâ„¢ platform …See details»
Curesponse | Scientist.com
The The Curesponse laboratory is ISO 15189 approved for both genomics and functional tests. The cResponseâ„¢ treatment selection assay, has been validated on animal models of cancer …See details»
Curesponse shows applicability of next generation Immuno …
Dec 21, 2022 Curesponse is a commercial stage precision oncology start up, maker of the cResponse platform, an AI-driven, functional-genomics drug prioritization technology. "We are …See details»
Curesponse shows applicability of next generation Immuno …
Dec 21, 2022 A poster presented at the recent ESMO Immuno-Oncology Congress in Geneva demonstrates that the cResponse platform can be applied for the modeling and evaluation of …See details»
The test that can predict which drugs will benefit individual cancer ...
Jun 29, 2023 Curesponse’ technology, called the cResponse TM test, makes it possible to simultaneously examine oncological treatments which the patient’s oncologist is considering …See details»
cResponse - Curesponse | Better Cancer Care
Curesponse’s 3D drug sensitivity assay presents an enormous opportunity for pharma companies working on drug development and clinical trials. In addition Curesponse provides a …See details»
Curesponse Presents Positive Preliminary Clinical Results
LONDON, England, May 9, 2023 (Newswire.com) - Curesponse, a commercial-stage precision oncology company, presented preliminary clinical results from a multi-center UK Study at the …See details»
News and Events - Curesponse | Better Cancer Care
Dec 21, 2022 Curesponse Announces Clalit Health Services, Largest Israeli HMO, to Provide Commercial Coverage for the cResponseâ„¢ test. Read more. Dec 21, 2022 Curesponse …See details»
Research and Evidence - Curesponse | Better Cancer Care
CResponseâ„¢ Research and Evidence The cResponseâ„¢ platform: A phase 2 clinical trial of cResponse, a functional assay for cancer precision medicine – Poster presented at the 2023 …See details»